Vyant Bio Inc (VYNT)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Results
download Want to compare other data? Select Fields| Symbol | VYNT | AZN | AMGN | GILD | VRTX |
| Company | Vyant Bio Inc | Astrazeneca Plc ADR | Amgen Inc | Gilead Sciences Inc | Vertex Pharmaceutic |
| Price Information | |||||
| Exchange | OTC US | NASDAQ | NASDAQ | NASDAQ | NASDAQ |
| Open | 0.1800 | 95.18 | 337.76 | 124.08 | 481.51 |
| High | 0.2000 | 95.95 | 341.46 | 125.11 | 485.69 |
| Low | 0.1750 | 95.15 | 337.76 | 123.73 | 478.79 |
| Latest | 0.1940 | 95.52 | 337.29 | 123.23 | 482.51 |
| Change | +0.0140 | +0.36 | -4.35 | -1.12 | -1.64 |
| % Change | +7.78% | +0.38% | -1.27% | -0.90% | -0.34% |
| Volume | 19,100 | 784,418 | 137,292 | 901,148 | 72,929 |
| 20-Day Average Volume | 32,920 | 4,544,632 | 2,690,310 | 6,140,186 | 1,218,596 |
| Previous Close | 0.1800 | 95.16 | 341.64 | 124.35 | 484.15 |
| Industry | Medical - Biomedical | Medical - Biomedical | Medical - Biomedical | Medical - Biomedical | Medical - Biomedical |
| Has Options | No | Yes | Yes | Yes | Yes |
| Technicals | |||||
| 20-Day Moving Average | 0.1727 | 92.05 | 327.76 | 122.54 | 457.85 |
| 20-Day Raw Stochastic | 85.33% | 90.18% | 87.58% | 67.90% | 95.20% |
| 20-Day Relative Strength | 61.39 | 66.28 | 58.52 | 52.82 | 67.45 |
| Weighted Alpha | -57.87 | +47.43 | +30.15 | +33.30 | +21.24 |
| Today's Opinion | 8% Sell | 100% Buy | 96% Buy | 72% Buy | 88% Buy |
| Previous Opinion | 32% Sell | 100% Buy | 96% Buy | 72% Buy | 88% Buy |
| Last Month's Opinion | 64% Sell | 100% Buy | 80% Buy | 80% Buy | 24% Buy |
| Performance | |||||
| 5-Days | |||||
| %Chg | +12.46% since 12/21/23 | +4.21% since 12/31/25 | +3.64% since 12/31/25 | +1.05% since 12/31/25 | +6.97% since 12/31/25 |
| Low | 0.1670 on 12/26/23 | 89.53 on 01/05/26 | 318.21 on 01/05/26 | 116.88 on 01/05/26 | 443.12 on 01/05/26 |
| High | 0.2000 on 12/29/23 | 96.51 on 01/07/26 | 343.05 on 01/07/26 | 125.10 on 01/08/26 | 487.52 on 01/07/26 |
| 1-Month | |||||
| %Chg | +9.30% since 11/29/23 | +4.95% since 12/08/25 | +5.61% since 12/08/25 | +2.34% since 12/08/25 | +9.71% since 12/08/25 |
| Low | 0.1591 on 12/11/23 | 89.28 on 12/12/25 | 312.39 on 12/11/25 | 116.88 on 01/05/26 | 433.81 on 12/10/25 |
| High | 0.2000 on 12/29/23 | 96.51 on 01/07/26 | 343.05 on 01/07/26 | 127.41 on 12/23/25 | 487.52 on 01/07/26 |
| 3-Month | |||||
| %Chg | +14.12% since 09/29/23 | +12.20% since 10/08/25 | +15.14% since 10/08/25 | +4.89% since 10/08/25 | +15.15% since 10/08/25 |
| Low | 0.1500 on 10/09/23 | 80.48 on 11/04/25 | 288.00 on 10/31/25 | 114.02 on 10/31/25 | 402.58 on 10/13/25 |
| High | 0.2100 on 11/02/23 | 96.51 on 01/07/26 | 346.38 on 12/03/25 | 128.70 on 11/20/25 | 487.52 on 01/07/26 |
| 6-Month | |||||
| %Chg | -3.00% since 06/29/23 | +36.82% since 07/08/25 | +14.22% since 07/08/25 | +11.68% since 07/08/25 | +3.98% since 07/08/25 |
| Low | 0.1410 on 09/25/23 | 68.61 on 07/21/25 | 269.77 on 09/26/25 | 107.75 on 07/21/25 | 362.50 on 08/11/25 |
| High | 0.2900 on 08/03/23 | 96.51 on 01/07/26 | 346.38 on 12/03/25 | 128.70 on 11/20/25 | 487.52 on 01/07/26 |
| Key Statistics | |||||
| Market Capitalization, $K | 1,228 | 295,134,176 | 183,966,656 | 154,278,560 | 122,838,048 |
| Shares Outstanding, K | 6,329 | 3,101,452 | 538,481 | 1,240,680 | 253,719 |
| Annual Sales | 670,000 | 54,073,000,000 | 33,424,000,000 | 28,754,000,000 | 11,020,100,000 |
| Annual Net Income | -22,690,000 | 7,035,000,000 | 4,090,000,000 | 480,000,000 | -535,600,000 |
| Last Quarter Sales | 120,000 | 15,191,000,000 | 9,557,000,000 | 7,769,000,000 | 3,076,400,000 |
| Last Quarter Net Income | -1,630,000 | 2,533,000,000 | 3,216,000,000 | 3,052,000,000 | 1,082,900,000 |
| 60-Month Beta | 1.68 | 0.34 | 0.45 | 0.33 | 0.31 |
| Per-Share Information | |||||
| Most Recent Earnings | N/A | 1.19 on 11/06/25 | 5.64 on 11/04/25 | 2.47 on 10/30/25 | 4.80 on 11/03/25 |
| Latest Earnings Date | 01/01/70 | 02/05/26 | 02/03/26 | 02/10/26 | 02/09/26 |
| Most Recent Dividend | N/A | 0.505 on 08/08/25 | 2.380 on 11/21/25 | 0.790 on 12/15/25 | N/A |
| Next Ex-Dividends Date | N/A | 08/08/25 | 02/13/26 | 12/15/25 | N/A |
| Ratios | |||||
| Price/Earnings ttm | 0.00 | 20.78 | 15.10 | 14.82 | 30.59 |